Organization | Poznan University

Poznan University Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Founded: Poznan Poland (1919)

Organization Overview

First Clinical Trial

2000

NCT03921736

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Alternative names

Anna Posadzy-Małaczyńska | Beata Krasinska | Department of Biochemistry, Poznan University of Physical Education, Poland | Department of Human Nutrition and Dietetics, Poznan University of Life Sciences, Wojska Polskiego 31, 60-624 Poznan, POLAND | Department of Hygiene and Human Nutrition, Poznan University of Life Sciences | Department of Hygiene and Human Nutrition, Poznan University of Life Sciences, Poznan, Poland | Department of Hypertension, Angiology and Internal Disease. Poznan University of Medical Sciences, Poland | Department of hypertension - School of Medicine - Poznan (Poland) | Department of Neonatology - Poznan University of Medical Sciences | Department of Paediatric Oncology, Haematology and Transplantology, University of Medical Sciences Poznan | Department of Respiratory Diseases, Allergology and Lung Oncology. Poznan University of Medical Sciences, Poland | Department of Sports Dietetics, Poznan University of Physical Education | Department oh Hypertension, Angiology and Internal Disease. University of Medical Sciences. Poznan,Poland | Heliodor Święcicki Clinical Hospital of the Poznań University of Medical Sciences | Institute of Human Nutrition and Dietetics, Poznań University of Life Sciences | Joanna Szurkowska | K Marcinkowski University of Med Sciences, Poznan, Poland | Medical University in Poznań | Poznan University of Life Sciences | Poznan University of Life Sciences, Poland | Poznan University of Life Sciences, ul. Wojska Polskiego 31, Poznań, Wielkopolska, Poland, 60-624 | Poznan University of Medical Sciences | Poznan University of Medical Sciences, Poland | Poznan University of Medical Sciences, Poznan, Poland | Poznan University of Medical Scienses | Poznan University of Physical Education | Poznan University of Physical Education, Poznan, Poland | University of Poznan | University of Poznan, CF center, Poland

Poznan University Report issue

Drugs in Phase 4 Trials (16)

Drugs in Phase 3 Trials (14)

Drugs in Phase 2 Trials (4)

Drugs in Other Trials (20)

Experimental Indications (Clinical Trials, Phases 1-4)

Overview